تخطي إلى المحتوى الرئيسي

growth differentiation factor 3

The GDF3 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF3 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. While the GDF3 protein is known to be involved in bone and cartilage development, its exact role is unclear.

اختيارات الفيديو لـ Genes
مكتبة الفيديو

Normal function

The GDF3 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF3 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. While the GDF3 protein is known to be involved in bone and cartilage development, its exact role is unclear.

The GDF3 protein is also involved in the development of the eyes, specifically the specialized light-sensitive tissue that lines the back of the eye called the retina.

Conditions referring to this gene or chromosome

Other names

GDF-3

growth/differentiation factor 3

Related patient information and medicines

سرطان الحنجرة

Patient information leaflet

سرطان الحنجرة

(The throat is usually spr... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. To confirm the diagnosis If anything suspicious is seen by the.

سرطان القضيب

Patient information leaflet

سرطان القضيب

ال exact reason why a cell becomes cancerous is un. It is thought that something damages or alters certain genes in the cell. By looking at certain features of the cells under the ... Grade 1 (low grade) - the cells look reasonably similar to normal cells. The cancer cells are said to be 'well differentiated'. Grade 2 - is a middle grade. Grade 3.

اعتلال الشبكية السكري

Patient information leaflet

اعتلال الشبكية السكري

New abnormal blood ... This is called proliferative retinopathy. These new vessels are delicate and can bleed easily. There are signs of blood flow becoming restricted but not yet showing new blood vessels growing (see below). Stage 3: proliferative retinopathy Proliferative retinopathy is the advanced diabetic retinopathy that occurs when damaged.

سرطان الثدي

Patient information leaflet

سرطان الثدي

Breast cancer is the most common cancer in women. What is breast cancer? | Patient Explainers Breast cancer is the most common cancer in women. Find out more: [/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Follow Patient: Website: [/](https://patient.info/) Facebook:.

ضخامة الأطراف

Patient information leaflet

ضخامة الأطراف

ضخامة الأطراف is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth.

ارتفاع ضغط الدم أثناء الحمل

Patient information leaflet

ارتفاع ضغط الدم أثناء الحمل

Developing chronic hypertension in later life. The risks to your baby include: An increased chance of poor growth and a low birth weight. An increased chance of premature birth Premature labour. You may be offered a placental growth factor blood test to help rule out pre-eclampsia between 20 weeks و up إلى 35 weeks of pregnancy, if you are.

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 30 Sept 2025 | أحدث إصدار
  • 1 Sept 2025 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

صيدلية إلكترونية وعلاجات وخدمات صحية

وصول بسيط إلى العلاجات والخدمات الصحية الموثوقة عبر الإنترنت.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.